Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits.
about
Proteinaceous Molecules Mediating Bifidobacterium-Host InteractionsBifidobacteria and Their Role as Members of the Human Gut MicrobiotaComposition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gapsAntiviral activity of Bifidobacterium adolescentis SPM1605 against Coxsackievirus B3Structural and thermodynamic analyses of solute-binding Protein from Bifidobacterium longum specific for core 1 disaccharide and lacto-N-biose IStructural basis for arabinoxylo-oligosaccharide capture by the probiotic Bifidobacterium animalis subsp. lactis Bl-04Gut Bifidobacteria Populations in Human Health and AgingGut bacteria in health and diseaseImproved detection of bifidobacteria with optimised 16S rRNA-gene based pyrosequencingBifidobacteria can protect from enteropathogenic infection through production of acetateProbiotics for vaginal health in South Africa: what is on retailers' shelves?Effect of the consumption of a fermented dairy product containing Bifidobacterium lactis DN-173 010 on constipation in childhood: a multicentre randomised controlled trial (NTRTC: 1571).Jerusalem artichoke and chicory inulin in bakery products affect faecal microbiota of healthy volunteers.Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers.Effect of probiotics on clinical and immune parameters in enthesitis-related arthritis category of juvenile idiopathic arthritis.Systematic review of randomised controlled trials: probiotics for functional constipationProteomic comparison of the cytosolic proteins of three Bifidobacterium longum human isolates and B. longum NCC2705A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients.Transitions in oral and intestinal microflora composition and innate immune receptor-dependent stimulation during mouse development.Genome-Wide Search for Genes Required for Bifidobacterial Growth under Iron-LimitationCharacterization of immunostimulatory CpG-rich sequences from different Bifidobacterium speciesSurvival and synergistic growth of mixed cultures of bifidobacteria and lactobacilli combined with prebiotic oligosaccharides in a gastrointestinal tract simulator.Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation.Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings.Overexpression, crystallization and preliminary X-ray analysis of xylulose-5-phosphate/fructose-6-phosphate phosphoketolase from Bifidobacterium breveRandomised clinical trial: efficacy of Lactobacillus paracasei-enriched artichokes in the treatment of patients with functional constipation--a double-blind, controlled, crossover study.Bifidobacteria-host interactions--an update on colonisation factors.Effects of green tea consumption on human fecal microbiota with special reference to Bifidobacterium species.Long-term changes in human colonic Bifidobacterium populations induced by a 5-day oral amoxicillin-clavulanic acid treatmentIn vitro kinetic analysis of fermentation of prebiotic inulin-type fructans by Bifidobacterium species reveals four different phenotypesIs Bifidobacterium breve effective in the treatment of childhood constipation? Results from a pilot study.Change of Fecal Flora and Effectiveness of the Short-term VSL#3 Probiotic Treatment in Patients With Functional ConstipationGut microbiome and metabolic diseases.Bifidobacteria exhibit LuxS-dependent autoinducer 2 activity and biofilm formation.Pediatric functional constipation treatment with Bifidobacterium-containing yogurt: a crossover, double-blind, controlled trial.Bifidobacterium commune sp. nov. isolated from the bumble bee gut.α-N-acetylgalactosaminidase from infant-associated bifidobacteria belonging to novel glycoside hydrolase family 129 is implicated in alternative mucin degradation pathway.Gut microbiome as a novel cardiovascular therapeutic target.The Host Genotype and Environment Affect Strain Types of Bifidobacterium longum subsp. longum Inhabiting the Intestinal Tracts of Twins.Improved adhesive properties of recombinant bifidobacteria expressing the Bifidobacterium bifidum-specific lipoprotein BopA
P2860
Q26740603-6CB70353-BC3D-43D6-949A-D824711C8290Q26744578-DAC24333-8B68-4538-B402-6FACBB47EE5AQ27006760-8FEC75C2-8D35-41E7-AEF9-AD7ACA5DD6D6Q27026206-9ADDC5C6-29B8-4C8D-BAAB-96EBABB98AB3Q27650045-50B20A61-E603-4927-8F80-422FF13EFE9CQ27687689-6E41415B-AD6A-465C-82D3-FE8998B138AEQ28071697-42322F55-F52B-494E-9368-0E54CED2971AQ28238138-43155BD3-F249-418A-B2B0-313A4ECAE1A3Q28730885-C813E14C-9F4E-4AC6-88C9-F7F6D3EDCC3BQ29617592-23F2DAB9-BE6E-427F-9C66-252CC8D7CE0DQ30835665-92B29788-8B16-4F23-B32B-0AF86D7A47D4Q33419501-2BE5A516-F7DC-4A9E-843C-56EE9A01EB11Q33437140-1D97BF55-3CE6-4DBC-984D-7A7D7993C4A3Q33438678-461CA169-A3A2-47EA-B46D-DF2A89D83730Q33468052-6E0EBAA5-9A7A-4B10-897B-22BAB724D6E2Q33521058-2D5D8BCC-459E-488F-A9B5-E1609E758A45Q33527552-B41C409B-12AC-4556-A59B-1AA35F5F5DFCQ33590786-01737179-A19A-4E2A-A143-48DC529A3510Q33613824-16F82276-43E0-4CB8-B9A9-9BC9C9339056Q33740694-C7182DC6-E5A6-4806-91FA-0B1A4E45E7E3Q33825921-730053B8-A1BB-42DF-804E-D819A7C11C65Q33912533-7F1C54B8-FF9E-48D5-AD90-5611A38219D8Q33960049-7EF37FDE-1E36-4E8E-9FF2-E320DB9B2342Q34021561-D4BBE8C3-6DEA-45FF-BD6A-76CE1C2A8350Q34049190-1BF0DBFF-311D-4DF3-B366-424D39F55410Q34245355-FD203D6B-4E90-4424-8063-97C72FB137C9Q34256838-9DB0CD99-88CC-4A47-B425-7609C8849668Q34394071-992D9ECB-2A94-445C-AE49-1E8E18E6AB4AQ34500072-0005E9BF-1456-4BAB-94C8-E02C150310FBQ34600329-388B322E-BD5F-44DD-9C01-DC8C3A622051Q34623410-493C21C5-8AF3-48EB-8821-A5000457E998Q34882090-7B79D31F-88FD-499A-8422-3936003FD0B6Q35033105-25F32828-901E-43A7-A36C-A1C8E3E7A789Q35088633-57EA517D-9E5C-46C4-9377-9BAA0D4BC0FFQ35404257-7D42DCDD-C1B8-4035-81E0-E395EFEE65E2Q35574061-FEB98E94-37CF-44AF-A14B-40C93EA31A5DQ35643847-9E6BA40F-DECB-4A55-8B85-48041BF0AC0FQ35909450-9E9402D4-C8EE-4AEF-BF96-6FD9555D9F11Q36000347-06C35B81-970C-4A9D-A9A0-53D0BD8B04FCQ36127787-E0CC1FE9-E406-443B-96E9-987F7B6B6979
P2860
Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Review article: bifidobacteria ...... effects and clinical benefits.
@ast
Review article: bifidobacteria ...... effects and clinical benefits.
@en
type
label
Review article: bifidobacteria ...... effects and clinical benefits.
@ast
Review article: bifidobacteria ...... effects and clinical benefits.
@en
prefLabel
Review article: bifidobacteria ...... effects and clinical benefits.
@ast
Review article: bifidobacteria ...... effects and clinical benefits.
@en
P2093
P2860
P1476
Review article: bifidobacteria ...... effects and clinical benefits.
@en
P2093
Fioramonti J
Francois A
Matuchansky C
Robinson T
P2860
P304
P356
10.1111/J.1365-2036.2005.02615.X
P407
P577
2005-09-01T00:00:00Z